Patent Assignment
Reel/Frame 052201/0503
First Supplement to Intellectual Property Security Agreement
Recorded: 2020-03-20
Pages: 5
Assignor
NABRIVA THERAPEUTICS GMBH
Executed: 2020-03-18
Assignee
HERCULES CAPITAL, INC.
400 HAMILTON AVENUE, SUITE 310, PALO ALTO, CALIFORNIA, 94301
Covered Properties
(2)
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
16/277,143 →
Publication:
US 2019/0175603
Purification of Pleuromutilin
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 1, 2019
From: HEILMAYER, WERNER; SPENCE, LEE; HINSMANN, PETER
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 049930/0721 →
Release of Security Interest
Jul 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064326/0977 →
Assignment of Assignor's Interest
Jan 9, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 069806/0458 →
Nunc Pro Tunc Assignment
Apr 3, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 070725/0291 →